Unit | Clinical Immunology

Our group focuses on systems-immunology-based approaches within the framework of Phase I to III clinical trials. We aim to identify surrogates of protection as well as host factors elicited by subunit and whole parasite vaccines against tuberculosis (TB) and malaria. Clinical trials are performed with our partners of the Ifakara Health Institute in Bagamoyo. Further, the unit develops novel diagnostic tools for paediatric clinical TB in high endemic countries.


Co-morbidity studies analyse the impact of non-communicable diseases on immune responses against infectious diseases, particularly TB. Unit researchers also work to understand the consequences of helminth co-infections on malaria, TB and HIV pathogenesis and immunity.

AbouZahr C et al. How can we accelerate progress on civil registration and vital statistics?. Bull World Health Organ. 2018(in press). DOI: 10.2471/BLT.18.211086

Accordini S et al. A three-generation study on the association of tobacco smoking with asthma. Int J Epidemiol. 2018(in press). (ALEC). DOI: 10.1093/ije/dyy031

Aljeesh Y.I, Alkhaldi M. Institutionalising community health programmes into the Palestinian health-care system: a qualitative study. Lancet, 2018;391:S36. DOI: 10.1016/s0140-6736(18)30361-1

Amek N.O et al. Infant and child mortality in relation to malaria transmission in KEMRI/CDC HDSS, Western Kenya: validation of verbal autopsy. Malar J. 2018;17:37. DOI: 10.1186/s12936-018-2184-x

Aminzadeh R et al. A multi-band body-worn distributed radio-frequency exposure meter: design, on-body calibration and study of body morphology. Sensors (Basel). 2018;18(1):e272. DOI: 10.3390/s18010272